Home > Press > ISE-CCM Nanotechnology Index is down -3.39% Year to Date
The ISE-CCM Nanotechnology Index (ISE: TNY) is down -3.39% year to date, versus 7.50% for the S&P 500, 11.74% for the DJIA, and 10.23% for the Nasdaq.
ISE-CCM Nanotechnology Index is down -3.39% Year to Date
New York, NY | Posted on October 11th, 2007
TNY was co-developed by Cronus Capital Markets and the International Securities Exchange (ISE) in New York. TNY comprises 17 of
the leading Nanotechnology companies such as; Cabot Corp. (NYSE: CBT), Headwaters Inc. (NYSE: HW), Symyx Technologies Inc. (NASDAQ: SMMX), and FEI COMPANY (NASDAQ: FEIC). TNY is currently trading options in the ISE.
Cronus Capital Markets CEO Michael Soni remarked that 'monthly index reports are an important feature of CCM's Index Support Program, especially for an index like TNY which covers an important aspect of the capital markets and receives significant investor interest.-
CCM Index Reports, available at no cost to investors and the media, include index descriptions, objectives, volatility analysis, performance returns, product specifications, component breakdowns and component profiles with news links. The TNY report is available on http://www.iseoptions.com
About Cronus Capital MarketsŪ (CCM)
Cronus Capital MarketsŪ (CCM) is a global investment information firm who strategically produces and introduces, through various forms of analytics and worldwide distribution, information on equity market opportunities. Our equity indexes receive international attention and represent important new benchmarks of growth.
For more information, please click here
Copyright © Cronus Capital MarketsŪ (CCM)
If you have a comment, please Contact
Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014
Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014
Harris & Harris Group Letter to Shareholders on Website August 19th, 2014
Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014
Ad-REIC vaccine: A magic bullet for cancer treatment September 30th, 2014
New Topical Hemostatic Agent: Neutral Self-Assembling Peptide Hydrogel September 30th, 2014
Chemical interactions between silver nanoparticles and thiols: A comparison of mercaptohexanol again September 30th, 2014
A Heartbeat Away? Hybrid "Patch" Could Replace Transplants: TAU researcher harnesses gold nanoparticles to engineer novel biocompatible cardiac patch September 30th, 2014